The perception of an increasing choice toward mastectomy has been confirmed at this institution. Possible reasons are younger population with higher lifetime risk, higher stage disease, and more biologically aggressive or diffuse tumors. Patient preference, fear of genetic or recurrence risk, and "intangible" factors seem to shift decisions toward mastectomy.

No abstract

Increasing demand for every faster information throughput is driving the emergence of integrated photonic technology. The traditional silicon platform used for integrated electronics cannot provide all of the functionality required for fully integrated photonic circuits, and thus, the last decade has seen a strong increase in research and development of hybrid and heterogeneous photonic integrated circuits. These approaches have enabled record breaking experimental demonstrations, harnessing the most favorable properties of multiple material platforms, while the robustness and reliability of these technologies are suggesting entirely new approaches for precise mass manufacture of integrated circuits with unprecedented variety and flexibility. This Tutorial provides an overview of the motivation behind the integration of different photonic and material platforms. It reviews common hybrid and heterogeneous integration methods and discusses the advantages and shortcomings. This Tutorial also provides an overview of common photonic elements that are integrated in photonic circuits. Finally, an outlook is provided about the future directions of the hybrid/heterogeneous photonic integrated circuits and their applications.

No abstract

No abstract

The increase in demand for agricultural products due to the growing population led to excessive inputs of pesticides in the agriculture field which resulted in contamination of the environmental segments of life i.e. air, water, and soil. Chlorpyrifos is one of the most extensively used broad-spectrum organophosphate insecticides. The usage and broad-spectrum applicability of chlorpyrifos lead to widespread contamination in the environment and serious damage to non-target organisms. Moreover, metabolites of chlorpyrifos i.e. chlorpyrifos-oxon and 3,5,6-trichloro-2-pyridinol are found to be more toxic than its parent compound. This review emphasizes on various toxic effects of chlorpyrifos and its metabolites on living organisms. The efforts put to develop the efficient methods for the degradation of the insecticide in soil and water i.e. photocatalytic, biodegradation, electrochemical and others have been discussed. Analytical techniques used for the study of degraded products and various intermediates formed during degradation under different conditions are summarized. It also includes the general pathway for the degradation of chlorpyrifos. The review will help in the development of tools for degradation and mineralization of organophosphate pesticides by knowing the mechanism of degradation and applicability of the developed process at a large scale.

ABSTRACT. In vitro-in vivo correlation (IVIVC) is a predictive mathematical model describing the relationship between an in vitro property and a relevant in vivo response. The main objective of an IVIVC is to serve as a surrogate for human bioequivalence (BE) studies, which may reduce the number of BE studies performed during the initial approval process as well as with certain scale-up and postapproval changes. The US Food and Drug Administration (FDA) published a regulatory guidance related to development, evaluation, and applications of IVIVC for extended-release (ER) oral dosage forms in September 1997. Despite the publication of this guidance, the deficiencies related to IVIVC are still identified by the Division of Bioequivalence in the process of Abbreviated New Drug Application (ANDA) review. Thus, the main objective of this article is to present the most commonly occurring deficiencies associated with IVIVCs via selected case studies from the ANDAs for oral ER drug products only. We searched internal FDA databases from January 1996 to December 2014 to identify the ANDAs for proposed generic oral ER drug products containing IVIVC. Only 14 ANDA submissions had IVIVC data, and most were not acceptable. Only one ANDA submission included adequate information related to IVIVC data enabling the completion of BE review within first review cycle. It is hoped that awareness of the deficiencies presented in our article would help the generic drug applicants to submit complete and appropriate information related to IVIVC data, ultimately, resulting in a more timely approval of ANDAs.

Reoperative SLN mapping and biopsy is feasible in the setting of local recurrence after previous CALND. This procedure performed for breast cancer recurrence provides important staging information while identifying extra-axillary drainage that could affect both staging and local control.